MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
AVI Biopharma
Attachments
Army
AVI BioPharma
Parents
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
*Industry: Washington
Children
AVI BioPharma Awarded $1.2 Million in U.S. Government Grants for Five Qualifying Therapeutic Development Projects Involving RNA-Based Drug Candidates (2010)
AVI BioPharma Awarded up to $291 Million U.S. Government Contract for Advanced Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses (2010)
AVI BioPharma's RNA-Based Influenza and Dengue Virus Programs to Be Presented (2010)
Bothell, Washington
By leveraging a highly differentiated RNA antisense-based technology platform has built a pipeline of therapeutic agents, including a clinical stage Duchenne muscular dystrophy candidate and anti-infective candidates for influenza & hemorrhagic fever virus
Developer of RNA-targeted therapies
Jumps
Karolinska Institute